India’s leading managed care platform serving 6 million lives across 450 cities in India and is planning to bring proven model to Malaysia
KUALA LUMPUR, July 14, 2025 – Three Malaysian siblings who left behind stable careers in strategic consulting and investment banking to revolutionise healthcare services are returning home with a proven business model, after securing backing from Hartamodal Sdn Bhd for their healthcare platform Connect & Heal.
The siblings – Galveen Kaur, Elwinder Singh and Salveen Kaur together with their Co-Founder & CEO Sanjay Vinayak, driven by personal circumstances and a noble intention to innovate healthcare systems, made the bold decision to build their venture in India’s challenging market rather than starting locally, due to India’s large market size and the opportunity to prove scalability in one of the world’s most complex healthcare environments.
“We are pleased to finally have our first Malaysian institutional venture capital firm that believes in our mission and supports us,” said Elwinder Singh, Co-Founder of Connect & Heal, noting Hartamodal’s unique position as the first Malaysian fund to invest in their venture.
Connect & Heal has become India’s leading managed care platform since its inception in 2017. Today they serve over 6 million lives, operate in 450 cities in India and complete over 1 million clinical transactions per annum.
They primarily serve multi-nationals and insurance companies extending managed care services to over 600 organisations across the country including over 30 Global Fortune 500 organisations.
Bringing Battle-Tested Innovation Home
As an integrated healthcare platform they provide end to end care management services including spanning telemedicine consultations, on-demand blood testing, pathology labs, ambulatory services and AI-powered engine for insurers.
“For me, building this company with my siblings and best friend, Elwin, Salveen and Sanjay, has made the journey all the more meaningful. They’ve been my rock. It’s powerful to have co-founders who not only challenge you but also have your back unconditionally. We started this with the hope of creating a greater impact — and doing it together as family has made that purpose even more special”, said Galveen the eldest of the three siblings.
The potential Malaysian expansion represents a homecoming for a venture that deliberately chose to prove their concept in one of the world’s most challenging healthcare environments. The experience has equipped them with unique insights into serving diverse populations, managing complex healthcare networks, and scaling technology solutions across multiple markets.
Strategic Malaysian Market Entry
“The reason they went to India is because it’s a bigger market, and they viewed it as a more difficult market to tackle with greater potential. Having managed to make traction in the market gives good confidence that they may replicate the same success in Malaysia,” said Tan Cheng Wen, Executive Director of Hartamodal.
The investment represents Hartamodal’s intention to support Malaysian founders – whether local or abroad – who have shown vision and execution ability, encouraging them to replicate their success back home. This comes against a backdrop where Malaysia’s healthcare system faces mounting pressure for revamp and improvement.
Investment Through Dana Impian Fund
Hartamodal, the venture capital subsidiary of Tradeview Capital, made the investment through its RM70 million Dana Impian fund, which targets Malaysian SMEs and Series A onwards startups across six sectors: healthcare technology, renewable energy, industrial manufacturing technology, agritech, consumer retail, and capital markets fintech.
The fund focuses on companies that are already EBITDA positive or cash flow positive, with typical investment tickets ranging from RM500,000 to RM10 million.
“We focus on backing founders with grit who can build and have the vision to tackle tough problems,” said Tan. “Dana Impian is all about giving opportunities to entrepreneurs and funding their dreams. Ultimately, we hope to support and invest in Malaysian founders with the ability to execute and help our country advance.”